Wegovy vs. Zepbound: Which FDA-Approved Weight-Loss Peptide Works Better?
Bottom line Zepbound (tirzepatide) demonstrated a greater average weight reduction of 20.2% compared to Wegovy (semaglutide) at 13.7% over 72 weeks in a head-to-head trial. This 6.5 percentage-point difference was both statistically and clinically significant. Comparison Factors: Beyond average weight loss, consider side-effect tolerance, drug mechanism, insurance coverage, and prescriber comfort. Regulatory Status: Both Wegovy […]
Wegovy vs. Zepbound: Which FDA-Approved Weight-Loss Peptide Works Better? Read More »









